Literature DB >> 22542714

Decreased fibrocyte number is associated with atherosclerotic plaque instability in man.

Lu Fang1, Xiao-Lei Moore, William Chan, David A White, Jaye Chin-Dusting, Anthony M Dart.   

Abstract

AIMS: Plaque rupture partly results from inadequate collagen synthesis due to lower smooth muscle cell numbers in fibrous caps. Fibrocytes are bone-marrow-derived circulating mesenchymal progenitors and have recently been identified in fibrous caps. This study hypothesized that reduced fibrocyte numbers would be associated with plaque instability. METHODS AND
RESULTS: Patients with acute myocardial infarction (MI) (n = 22), stable angina (SA) (n = 20), or healthy controls (n = 22) were recruited. Circulating fibrocytes (CD45(+)/CD34(+)/collagen I(+)) were measured by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from blood and cultured for 2 weeks, and fibrocytes were quantified by morphology (spindle-shaped) and flow cytometry (CD45(+)/collagen I(+)). Another set of PBMCs was stimulated with macrophage colony-stimulating factor (M-CSF) for 72 h and the expression of several macrophage markers was measured by flow cytometry. Acute MI patients had decreased circulating fibrocyte numbers compared with healthy controls or SA patients. Following 2 weeks' culture, both the number of spindle-shaped fibrocytes counted under the microscope and the percentage of fibrocytes of the remaining adherent cells in culture measured by flow cytometry were reduced in acute MI patients. Expression of macrophage markers CD68, CD36, and EMR in M-CSF-stimulated PBMCs was enhanced in acute MI patients compared with the other two groups. SA patients with previous MI had decreased circulating fibrocyte numbers and a lower yield of fibrocytes from PBMCs than those without previous MI.
CONCLUSIONS: This is the first report of decreased fibrocyte numbers in patients with MI. Reduced fibrocytes and preferential differentiation of PBMCs into macrophages may contribute to plaque instability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542714     DOI: 10.1093/cvr/cvs156

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Circulating fibrocytes as predictors of adverse events in unstable angina.

Authors:  Ellen C Keeley; Robert C Schutt; Mark A Marinescu; Marie D Burdick; Robert M Strieter; Borna Mehrad
Journal:  Transl Res       Date:  2016-03-08       Impact factor: 7.012

2.  Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.

Authors:  Thomas M Hofbauer; Anna S Ondracek; Andreas Mangold; Thomas Scherz; Johanna Nechvile; Veronika Seidl; Christine Brostjan; Irene M Lang
Journal:  Front Cell Dev Biol       Date:  2020-11-09

3.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

Review 5.  Systemic inflammatory response following acute myocardial infarction.

Authors:  Lu Fang; Xiao-Lei Moore; Anthony M Dart; Le-Min Wang
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

6.  Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy.

Authors:  Lu Fang; Anna Beale; Andris H Ellims; Xiao-Lei Moore; Liang-Han Ling; Andrew J Taylor; Jaye Chin-Dusting; Anthony M Dart
Journal:  J Am Heart Assoc       Date:  2013-10-14       Impact factor: 5.501

7.  Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction.

Authors:  Thomas M Hofbauer; Andreas Mangold; Thomas Scherz; Veronika Seidl; Adelheid Panzenböck; Anna S Ondracek; Julian Müller; Matthias Schneider; Thomas Binder; Lena Hell; Irene M Lang
Journal:  Basic Res Cardiol       Date:  2019-07-16       Impact factor: 17.165

Review 8.  Role of Circulating Fibrocytes in Cardiac Fibrosis.

Authors:  Rong-Jie Lin; Zi-Zhuo Su; Shu-Min Liang; Yu-Yang Chen; Xiao-Rong Shu; Ru-Qiong Nie; Jing-Feng Wang; Shuang-Lun Xie
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

9.  Enumeration of circulating fibrocytes for clinical use in asthma by an optimized single-platform flow cytometry assay.

Authors:  Lorenza Bianchetti; Mirko Isgrò; Maurizio A Marini; Alberto Bellini; Matthias Schmidt; Sabrina Mattoli
Journal:  BBA Clin       Date:  2014-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.